John D. Simpson Net Worth

The estimated Net Worth of John D. Simpson is at least $285 Thousand dollars as of 20 July 2016. John Simpson owns over 32,500 units of Avinger Inc stock worth over $80,663 and over the last 8 years John sold AVGR stock worth over $204,100.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

John Simpson AVGR stock SEC Form 4 insiders trading

John has made over 1 trades of the Avinger Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently John sold 32,500 units of AVGR stock worth $204,100 on 20 July 2016.

The largest trade John's ever made was selling 32,500 units of Avinger Inc stock on 20 July 2016 worth over $204,100. On average, John trades about 10,833 units every 0 days since 2016. As of 20 July 2016 John still owns at least 69,537 units of Avinger Inc stock.

You can see the complete history of John Simpson stock trades at the bottom of the page.

What's John Simpson's mailing address?

John's mailing address filed with the SEC is 400, Chesapeake Drive, Redwood City, San Mateo County, California, 94063, United States.

Insiders trading at Avinger Inc

Over the last 10 years, insiders at Avinger Inc have traded over $4,931,811 worth of Avinger Inc stock and bought 65,650 units worth $291,405 . The most active insiders traders include John B Ph D Md Simpson, James Cullen, and Jeffrey M Soinski. On average, Avinger Inc executives and independent directors trade stock every 57 days with the average trade being worth of $43,246. The most recent stock trade was executed by Nabeel Paul Subainati on 22 March 2023, trading 417 units of AVGR stock currently worth $484.

What does Avinger Inc do?

avinger, inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (pad). pad is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. the company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. avinger’s current lumivascular products include the lightbox imaging console, the ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or ctos, and pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in pad patients.

Complete history of John Simpson stock trades at Avinger Inc

Avinger Inc executives and stock owners

Avinger Inc executives and other stock owners filed with the SEC include:

• Jeffrey Soinski,
  President, Chief Executive Officer, Director
• Himanshu Patel,
  Chief Technology Officer
• Mark Weinswig,
  Chief Financial Officer
• Jeffrey M. Soinski,
  Pres, CEO & Director
• Himanshu N. Patel,
  Chief Technology Officer
• Mark B. Weinswig,
  Chief Financial Officer
• James McElwee,
  Independent Director
• Donald Lucas,
  Independent Director
• Tamara Elias,
  Director
• Jaafer Golzar,
  Chief Medical Officer
• James Cullen,
  Independent Chairman of the Board
• Nabeel Subainati,
  VP, Controller, Principal Financial Officer & Accounting Officer
• Keith Schaefer,
  Chief Operating Officer
• Sougata Banerjee,
  Senior VP of Operations
• John D. Simpson,
  Sr. VP, Sales & Marketing
• Arjun Desai,
  Chief Medical Officer
• John B Ph D Md Simpson,
  Executive Chairman
• Thomas J M D Fogarty,
  Director
• Matthew Ferguson,
  Chief Business Officer and CFO
• Bush Simpson & Rita Lynn Si...,
  10% owner
• Donald A Lucas Venture Grou...,
  
• Nabeel Paul Subainati,
  Vice President, Finance
• Group L.P.Crg Partners Iii ...,